Uncertainty-Aware Brain-Tumor Type Classification From MRI: Segmentation-Guided ROI, Conformal Prediction, and Selective Abstention Under Distribution Shift
An uncertainty-aware classification framework is presented that couples segmentation-guided region-of-interest (ROI) localization with post-hoc calibration, split-conformal prediction, and selective abstention, and a deferral rule that abstains on unreliable inputs.
Abstract
Reliable classification of brain-tumor type from magnetic resonance imaging (MRI) is essential for treatment planning and patient management. While deep neural networks achieve high accuracy on this task, they typically produce point predictions without a measure of reliability, and their confidence need not fall when image quality departs from the training distribution. An uncertainty-aware classification framework is presented that couples segmentation-guided region-of-interest (ROI) localization with post-hoc calibration, split-conformal prediction, and selective abstention: a U-Net localizes the tumor; the cropped region is classified; and the prediction is equipped with a calibrated confidence, a conformal set with a distribution-free coverage guarantee, and a deferral rule that abstains on unreliable inputs. All experiments used the Figshare brain-tumor dataset under leakage-free patient-level cross-validation. ROI localization improved patient-level balanced accuracy from 93.8% to 96.1% with a predicted mask while also improving calibration, and the 90% conformal coverage held under deployment with a predicted mask. Under bias-field, blur, and gamma corruptions, where exchangeability no longer holds, the empirical coverage degraded but was restored by recalibration and patient-aware inference, while the abstention rate rose with severity. The exchangeable unit for a valid guarantee is shown to be the patient, not the slice: slice-level calibration met the intended per-patient coverage in only 27% of resampled splits, versus 84% for patient-level calibration. The reliability layer further transfers to a four-class benchmark that adds healthy scans.
Confidence- and entropy-based abstention produced a measurable reduction in selective risk at low rejection rates, and it did so because errors concentrated among the cases were withheld by the confidence/entropy rule rather than because predictions were discarded indiscriminately.
The results demonstrate that segmentation-guided ROI extraction combined with deep feature-based classification and weighted probabilistic fusion provides an effective approach for automated brain tumor analysis.
D. M., D. Edla, A. Singh et al.· Evolutionary Bioinformatics· 0 citations
A three-phase hybrid MRI framework based on the coordinated allocation of complementary tasks that integrates interpretable feature optimization, efficient tumor categorization, and spatial localization is proposed.
Samira Babaahmadi Milani, Erfaneh Noroozi, Mehdi Hosseinzadeh· Journal of Supercomputing· 0 citations
SYNAPSE-X is presented as a research-stage reliability-assessment framework for calibrated brain tumor MRI classification, supporting uncertainty-aware referral while acknowledging limitations related to public image-level datasets, unavailable patient-level identifiers, and the need for prospective clinical validation...
Sadaf Tabatabaee, M. Khasawneh· Neural computing & applicati...· 0 citations
A unified deep learning framework that integrates ensemble-based brain tumor classification, U-Net-based tumor segmentation, and Grad-CAM explainability for automated brain MRI analysis is proposed and demonstrates the effectiveness of integrating ensemble classification, tumor segmentation, and explainable artificial...
Rashmitha R. Nayak, Ramyashree, S. Raghavendra et al.· Discover Artificial Intellig...· 0 citations
PURPOSE
Despite remarkable auto-segmentation performance and growing clinical adoption, models frequently fail to generalize beyond the training distribution. Therefore, this study aimed to develop and validate an uncertainty-aware segmentation pipeline that yields high delineation accuracy for liver cancer patients an...
D. Langner, C. Gani, S. Boeke et al.· Radiotherapy and Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.